- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
13
Stocks where the price continues to rise after more than a year of consistent gains.
13 companies
Hansa Biopharma
Market Cap: SEK 4.0b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 39.42
7D
21.9%
1Y
42.0%
Prescient Therapeutics
Market Cap: AU$96.7m
A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.
PTX
AU$0.092
7D
26.0%
1Y
104.4%
PharmaCielo
Market Cap: CA$16.7m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.075
7D
25.0%
1Y
50.0%
Invex Therapeutics
Market Cap: AU$9.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.12
7D
20.0%
1Y
44.6%
Delex Healthcare Group
Market Cap: US$5.1m
Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
DELX
US$0.0085
7D
46.6%
1Y
9.8%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
International Stem Cell
Market Cap: US$2.5m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.31
7D
74.4%
1Y
107.8%
CBD Life Sciences
Market Cap: US$1.8m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0003
7D
200.0%
1Y
0%
Myrexis
Market Cap: US$241.4k
Focuses on identifying, evaluating, and making financial investments in life sciences assets.
MYRX
US$0.007
7D
775.0%
1Y
3,400.0%
Bright Green
Market Cap: US$133.8k
Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.
BGXX.Q
US$0.0007
7D
250.0%
1Y
69,900.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
Pressure BioSciences
Market Cap: US$30.1k
Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.
PBIO
US$0.0007
7D
250.0%
1Y
133.3%
eFFECTOR Therapeutics
Market Cap: US$3.8k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
33.3%
1Y
300.0%